Erythematous and Vascular Oral Mucosal Lesions: A Clinicopathologic Review of Red Entities.
McNamara KK, Kalmar JR.
Head Neck Pathol. 2019 Mar;13(1):4-15. doi: 10.1007/s12105-019-01002-8. Epub 2019 Jan 29.
Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, Geisinger ML, Genco RJ, Glogauer M, Goldstein M, Griffin TJ, Holmstrup P, Johnson GK, Kapila Y, Lang NP, Meyle J, Murakami S, Plemons J, Romito GA, Shapira L, Tatakis DN, Teughels W, Trombelli L, Walter C, Wimmer G, Xenoudi P, Yoshie H.
J Periodontol. 2018 Jun;89 Suppl 1:S74-S84. doi: 10.1002/JPER.17-0719.
Extra-vascular type of oral intravascular papillary endothelial hyperplasia (Masson's tumor) of lower lip: a case report and review of the literature.
Sarode GS, Sarode SC.
Indian J Dent Res. 2015 Jan-Feb;26(1):101-5. doi: 10.4103/0970-9290.156825.
A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice.
Morishima Y, Honda Y.
J Thromb Thrombolysis. 2018 Jul;46(1):95-101. doi: 10.1007/s11239-018-1673-7.
Histopathological Study of Oral Pseudoepitheliomatous Hyperplasia.
Pascu RM, Crăiţoiu Ş, Florescu AM, Dăguci L, Petcu IC, Pascu EG, Crăiţoiu MM.
Curr Health Sci J. 2017 Oct-Dec;43(4):361-366. doi: 10.12865/CHSJ.43.04.13. Epub 2017 Dec 28.
Vascular stent with immobilized anti-inflammatory chemerin 15 peptides mitigates neointimal hyperplasia and accelerates vascular healing.
Wen L, Qiu H, Li S, Huang Y, Tu Q, Lyu N, Mou X, Luo X, Zhou J, Chen Y, Wang C, Huang N, Xu J.
Acta Biomater. 2024 Apr 15;179:371-384. doi: 10.1016/j.actbio.2024.02.022. Epub 2024 Feb 20.
Mandibular condylar hyperplasia and its correlation with vascular endothelial growth factor.
Almeida LE, Cicciù M, Doetzer A, Beck ML, Cervino G, Minervini G.
J Oral Rehabil. 2023 Sep;50(9):845-851. doi: 10.1111/joor.13487. Epub 2023 May 18.
Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, Geisinger ML, Genco RJ, Glogauer M, Goldstein M, Griffin TJ, Holmstrup P, Johnson GK, Kapila Y, Lang NP, Meyle J, Murakami S, Plemons J, Romito GA, Shapira L, Tatakis DN, Teughels W, Trombelli L, Walter C, Wimmer G, Xenoudi P, Yoshie H.
J Clin Periodontol. 2018 Jun;45 Suppl 20:S68-S77. doi: 10.1111/jcpe.12940.
Oral intra vascular papillary endothelial hyperplasia in the floor of the mouth.
Devi M, Nalin Kumar S, Ranganathan K, Saraswathi TR.
Indian J Dent Res. 2004 Oct-Dec;15(4):149-51.
Histomorphometric comparative analysis between the oral mucosa of fibrous inflammatory hyperplasia and oral leukoplakia.
da Silva GDG, Pinheiro TN.
Transl Cancer Res. 2020 Apr;9(4):3101-3106. doi: 10.21037/tcr.2019.12.23.
